MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-27-2026
Retractable Technologies Long Term Debt Current 2011-2026 | RVP
Annual Long Term Debt Current Retractable Technologies
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 286 K | 289 K | 38.9 K | 82.4 K | 406 K | 411 K | 430 K | 249 K | 150 K | 247 K | 315 K | 620 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 620 K | 38.9 K | 294 K |
Long Term Debt Current of other stocks in the Medical instruments industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
iRhythm Technologies
IRTC
|
16.7 M | $ 122.35 | - | $ 3.92 B |  USA |
 |
Repro Med Systems
KRMD
|
413 K | $ 3.96 | - | $ 183 M | USA |
 |
Milestone Scientific
MLSS
|
130 K | $ 0.32 | 1.28 % | $ 26.3 M | USA |
 |
Alcon
ALC
|
80 M | $ 75.8 | - | $ 40.4 B |  Schweiz |
 |
STERIS plc
STE
|
34.2 M | $ 221.8 | - | $ 21.9 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
441 K | $ 10.99 | - | $ 26.7 M | USA |
 |
Teleflex Incorporated
TFX
|
100 M | $ 136.56 | - | $ 6.09 B | USA |
 |
The Cooper Companies
COO
|
37.8 M | $ 64.42 | - | $ 12.8 B | USA |
 |
Utah Medical Products
UTMD
|
60 K | $ 67.17 | - | $ 218 M | USA |
 |
Haemonetics Corporation
HAE
|
8.11 M | $ 59.93 | - | $ 3.02 B | USA |
 |
electroCore
ECOR
|
375 K | $ 6.18 | -0.08 % | $ 52.4 K | USA |
 |
ICU Medical
ICUI
|
13.8 M | $ 124.82 | 0.22 % | $ 3.08 B | USA |
 |
Envista Holdings Corporation
NVST
|
39 M | $ 26.8 | - | $ 4.5 B | USA |
 |
Microbot Medical
MBOT
|
296 K | $ 2.2 | - | $ 101 M |  Israel |
 |
West Pharmaceutical Services
WST
|
22.7 M | $ 306.16 | - | $ 22.1 B | USA |
 |
Isoray
ISR
|
623 K | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
39 M | $ 482.22 | - | $ 172 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
47 M | $ 11.91 | - | $ 2.37 B | USA |
 |
Glaukos Corporation
GKOS
|
1.31 M | $ 121.48 | - | $ 5.88 B | USA |
 |
Masimo Corporation
MASI
|
21.4 M | $ 178.63 | - | $ 9.52 B | USA |
 |
InfuSystem Holdings
INFU
|
349 K | $ 10.34 | - | $ 214 M | USA |
 |
Merit Medical Systems
MMSI
|
10.9 M | $ 68.58 | - | $ 4.06 B | USA |
 |
Pulse Biosciences
PLSE
|
1.57 M | $ 23.02 | - | $ 1.55 B | USA |
 |
LeMaitre Vascular
LMAT
|
2.94 M | $ 113.45 | - | $ 2.57 B | USA |
 |
Predictive Oncology
POAI
|
654 K | - | - | $ 31.1 M | USA |
 |
STAAR Surgical Company
STAA
|
5.87 M | $ 25.67 | - | $ 1.27 B | USA |
 |
BioLife Solutions
BLFS
|
1.51 M | $ 21.38 | - | $ 985 M | USA |
 |
Stereotaxis
STXS
|
642 K | $ 1.93 | - | $ 176 M | USA |
 |
Baxter International
BAX
|
81 M | $ 18.16 | - | $ 9.32 B | USA |
 |
ResMed
RMD
|
21.9 M | $ 219.85 | - | $ 32.1 B | USA |
 |
AtriCure
ATRC
|
1.73 M | $ 29.28 | - | $ 1.4 B | USA |
 |
Harvard Bioscience
HBIO
|
1.52 M | $ 6.86 | 1.18 % | $ 305 M | USA |
 |
NeuroMetrix
NURO
|
107 K | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
1.84 M | $ 11.1 | - | $ 453 M | USA |
 |
Becton, Dickinson and Company
BDX
|
135 M | $ 152.14 | - | $ 43.8 B | USA |
 |
Nephros
NEPH
|
442 K | $ 2.87 | 1.06 % | $ 29.8 M | USA |
 |
OraSure Technologies
OSUR
|
2.16 M | $ 3.0 | -1.64 % | $ 220 M | USA |
 |
Repligen Corporation
RGEN
|
5.63 M | $ 117.6 | - | $ 6.55 M | USA |